IBM initiated at Outperform as software accelerates at Big Blue: Oppenheimer
IBM (NYSE:IBM) was initiated with an Outperform rating by Oppenheimer due in part to double-digit revenue growth in its software segment, driven by its Red Hat offerings. "Red Hat specifically has ...
Viking Therapeutics initiated with a Neutral at Citi
Citi analyst David Lebowitz initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $38 price target Viking’s VK2735 is an ...